Semiconductor company Archer Materials (ASX: AXE) has made notable technology development progress with its 12CQ quantum chip and its Biochip lab-on-a-chip technology. To progress the 12CQ chip development, Archer designed, developed and built a new type of device called a pulsed electron spin resonance (p-ESR) chip. Archer was able to leverage the expertise of Swiss-based
Read MoreAustralian semiconductor company Archer Materials (ASX: AXE) has joined forces with Switzerland’s research institute École Polytechnique Fédérale de Lausanne (EPFL) to build a microchip aimed at revolutionising the study of quantum materials. The chip’s features open potential opportunities for Archer to develop quantum sensors, miniaturised spectrometers, and analytical devices for precision sensing. This new chip,
Read MoreThis is no wee bit of news; it’s a major milestone for Aussie semiconductor company Weebit Nano (ASX: WBT). The Company, known for developing advanced memory technologies for the global semiconductor industry, has received its first IP licensing revenue worth $153,536 (US$100k) for its embedded Resistive Random-Access Memory (ReRAM) technology. Though this revenue is small,
Read MoreSemiconductor company Archer Materials (ASX: AXE) has just hit a new milestone: an upgrade for its gFET (graphene field effect transistor) biochip design, aimed to enhance disease detection and control. This comes just a few weeks after it engaged with commercial foundry partners in Germany to begin a multi-project wafer run (an ‘MPW’) of the
Read MoreIn the rapidly advancing field of quantum computing, Archer Materials (ASX: AXE) has managed to make groundbreaking progress. The Australian semiconductor company has been pushing the boundaries of quantum coherence times and making significant strides towards commercialising their qubit processor technology without the hype or overspending. Quantum coherence time, a critical metric in quantum computing,
Read MoreAustralian semiconductor company Archer Materials (ASX: AXE) has taken a major step forward towards the commercialisation of its biosensing graphene transistor technology with the transfer of its chip designs to a commercial foundry to initiate a production run. The company’s partnerships with international semiconductor fabs have advanced this year, with Archer having completed its optical
Read MoreThe content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.